UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
SD
SPECIALIZED
DISCLOSURE REPORT
Medigus
Ltd
.
(Exact
name of registrant as specified in its charter)
Israel
|
|
001-37381
|
|
Not
Applicable
|
(State
or other jurisdiction of
incorporation or organization)
|
|
(Commission
file number)
|
|
(IRS
Employer
Identification No.)
|
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address
of principal executive offices) (Zip code)
Oded
Yatzkan, +972-72-2602200
(Name
and telephone number, including area code, of the person to contact in connection with this report)
Check
the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information
in this form applies:
☒
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2017.
SECTION
1 – CONFLICT MINERALS DISCLOSURE
Overview
Item
1.01 Conflict Minerals Disclosure and Report
References
in this report to “Medigus,” “our Company,” “we,” “our,” or “us” mean
Medigus Ltd. together with its consolidated subsidiary, except where the context otherwise requires.
Our
Conflict Minerals Policy
We
fully support Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD (collectively, the “Conflict
Minerals Rule”) and are committed to responsible sourcing of Conflict Minerals (as defined below) as well as full compliance
with the requirements of the Conflict Minerals Rule. Medigus is committed to identifying the potential Conflict Minerals which
are necessary to the functionality or production of products manufactured by Medigus or for Medigus by a third party manufacturer
and determining the country of origin of any potential Conflict Minerals.
In
furtherance of the foregoing, we have adopted and communicated to our suppliers and the public a company policy (the “Conflict
Minerals Policy”) for the supply chain of Conflict Minerals. As used herein and in the Conflict Minerals Policy, “Conflict
Minerals” consist of columbite-tantalite (coltan), cassiterite, gold, wolframite and the derivatives tantalum, tin and tungsten,
without regard to the location of origin.
Our
Conflict Minerals Policy indicates that suppliers who do not comply with the foregoing expectations will be reviewed and evaluated
accordingly for future business and sourcing decisions.
Applicability
of the Conflict Minerals Rule to Our Company
A
review of our products was completed in 2018 (covering the 2017 period). It was determined that Conflict Minerals could feasibly
be found within or as part of our Medigus Ultrasonic Surgical Endostapler, or MUSE™, system, including its component products,
which consist of a single-use endostapler, a miniature camera and ultrasound sensor, as well as a control console offering a video
image transmitted from the tip of the endostapler: We furthermore determined that Conflict Minerals could potentially be contained
in the other products that we are developing, including miniaturized video cameras for use in various medical
procedures,
as
well as specialized industrial applications.
We
believe that we are in most cases many levels removed from mines, smelters and refiners and have limited influence over the mines,
smelters, refiners and many of the other vendors in our supply chain. However, through the efforts described in this Form SD and
the Conflict Minerals Report included as an exhibit hereto, we seek to ensure that our sourcing practices are consistent with
our Conflict Minerals Policy and to encourage conflict-free sourcing in our supply chain.
Reasonable
Country of Origin Information
In
connection with the reasonable country of origin inquiry (“RCOI”) required by the Conflict Minerals Rule, we utilized,
for our RCOI, the same process and procedures established for our due diligence. For our due diligence, we sent questionnaires
to all of our suppliers in which we inquired as to the source of materials that they supply for our products that we believe may
contain Conflict Minerals, requesting that they provide us with information concerning the identity and location of such source.
Despite
our RCOI and ongoing due diligence, we do not yet have sufficient information to determine the country of origin of the Conflict
Minerals used in our products or to identify the facilities used to process those Conflict Minerals.
Therefore,
we cannot exclude the possibility that some of those Conflict Minerals may have originated in the Democratic Republic of the Congo
or an adjoining country and/or are not from recycled or scrap sources.
As
such, our products— consisting of the MUSE™ system and all components thereof, as well as miniaturized video cameras
for use in various medical
procedures
and certain specialized industrial
applications— that we produced in calendar year 2017, are “DRC Conflict Undeterminable.” As a result we have
filed a Conflict Minerals Report.
Website
Disclosure
As
required by the Conflict Minerals Rule, the foregoing information and our full “Conflict Minerals Policy” is available
at our Internet website—
www.medigus.com
(under “Investors”—“SEC Filings”). The information
contained on our website is not incorporated by reference into this Form SD or our Conflict Minerals Report and should not be
considered part of this Form SD or our Conflict Minerals Report.
Item 1.02
Exhibit
The
Conflict Minerals Report required by Item 1.01 is filed as Exhibit 1.01 to this Form SD.
As
required by the Conflict Minerals Rule, a Conflict Minerals Report is provided as an exhibit to this Form SD and is available
at our Internet website—
www.medigus.com
(under “Investors”—“SEC Filings”).
SECTION
2 – EXHIBITS
Item
2.01 Exhibits
Signature
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the duly authorized undersigned.
Medigus
Ltd.
(Registrant)
By:
|
/s/
Oded Yatzkan
|
|
May 31, 2018
|
|
Oded
Yatzkan
|
|
Date
|
|
Chief
Financial Officer
|
|
|
3
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024